Skip to main content
. 2017 Dec 19;9(7):7322–7331. doi: 10.18632/oncotarget.23467

Table 2. Development or worsening of CIPN.

n (row%) All Prior neuropathy no Prior neuropathy yes
Li or VPA CIPN no CIPN yes total CIPN no CIPN yes total CIPN no CIPN yes total
no 66 (60) 44 (40) 110 59 (65) 32 (35) 91 7 (37) 12 (63) 19
yes 4 (100) 0 (0) 4 3 (100) 0 (0) 3 1 (100) 0 (0) 1
total 70 (61) 44 (39) 114 62 (65) 32 (35) 94 8 (40) 12 (60) 20